Lactonic sophorolipid
Lactonic sophorolipid is an apoptosis inducer and antimicrobial surfactant with antitumor activity. Lactonic sophorolipid regulates Bax/Bcl-gene expression through caspase-3/9 and induces apoptosis in tumor cells. Lactonic sophorolipid can disrupt cell membrane permeability and exert antibacterial effects (MIC for oral pathogens is 100-400 μg/mL) . Lactonic sophorolipid promotes mitochondrial membrane potential depolarization, activates the intrinsic apoptotic pathway, and can synergize with antibiotics to enhance the antibacterial effect. Lactonic sophorolipid can be used in liver cancer research and the development of oral hygiene antibacterial agents[1][2][3].
Product Specifications
CAS Number
148409-20-5
UNSPSC
12352005
Target
Antibiotic; Apoptosis; Bacterial
Type
Reference compound
Related Pathways
Anti-infection; Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/lactonic-sophorolipid.html
Purity
97.31
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
O[C@@H]1[C@]2([H])[C@@](O[C@H](CCCCCC/C=C\CCCCCCCC(O[C@]3([H])[C@H](O[C@@]([C@@H]([C@H]3O)O)([H])O2)COC(C)=O)=O)C)([H])O[C@@H]([C@H]1O)COC(C)=O
Molecular Formula
C34H56O14
Molecular Weight
688.80
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD50 / ICAM3 (CG106), CF568 conjugate, 0.1mg/mL
Pmel17 / gp100 / SILV (NKI-beteb), CF405S conjugate, 0.1mg/mL
Fibronectin (TV-1), CF594 conjugate, 0.1mg/mL
CD16 (C16/1045), CF640R conjugate, 0.1mg/mL
CD106 / VCAM1 (1.4C3), CF647 conjugate, 0.1mg/mL
